Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Testicular Neoplasms × Control Groups × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 34 Neoplasms 21 Motor Activity 10 Fatigue 7 Colorectal Neoplasms 7 Stomach Neoplasms 6 Pain, Postoperative 6 Lung Neoplasms 6 Pain 5 Anxiety Disorders 5 Polycystic Ovary Syndrome 4 Depression 4 Uterine Cervical Neoplasms 3 Thyroid Neoplasms 3 Stomatitis 3 Sleep Initiation and Maintenance Disorders 3 Malnutrition 3 Colonic Neoplasms 3 Carcinoma, Hepatocellular 3 Agnosia 3 Vomiting 2 Squamous Cell Carcinoma of Head and Neck 2 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Parasomnias 2 Ovarian Neoplasms 2 Nausea 2 Lymphatic Metastasis 2 Liver Neoplasms 2 Leukemia, Myeloid, Acute 2

Interventions

Carboplatin 16 Etoposide 15 Ifosfamide 14 Filgrastim 14 Peripheral Blood Stem Cell Transplantation 12 Paclitaxel 11 Cisplatin 10 Cyclophosphamide 9 Thiotepa 5 Therapeutics 5 Radiotherapy 5 Melphalan 4 Magnetic Resonance Spectroscopy 4 Gemcitabine 4 Flow Cytometry 4 Busulfan 4 etoposide phosphate 3 Psychiatric Rehabilitation 3 Methylprednisolone 3 Methods 3 Immunologic Techniques 3 Granulocyte Colony-Stimulating Factor 3 Epirubicin 3 Dexamethasone 3 Blood Specimen Collection 3 tremelimumab 2 pegfilgrastim 2 durvalumab 2 Watchful Waiting 2 Vinblastine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02577172 2017-01-26

TAST

Oslo University Hospital

Phase NA Terminated

Motor Activity, Testicular Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡